Literature DB >> 19492416

Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells.

Elena M Rodriguez1, Elizabeth E Dunham, G Steven Martin.   

Abstract

Atypical protein kinase C (aPKC) isoforms have been shown to mediate Src-dependent signaling in response to growth factor stimulation. To determine if aPKC activity contributes to the transformed phenotype of cells expressing oncogenic Src, we have examined the activity and function of aPKCs in 3T3 cells expressing viral Src (v-Src). aPKC activity and tyrosine phosphorylation were found to be elevated in some but not all clones of mouse fibroblasts expressing v-Src. aPKC activity was inhibited either by addition of a membrane-permeable pseudosubstrate, by expression of a dominant-negative aPKC, or by RNAi-mediated knockdown of specific aPKC isoforms. aPKC activity contributes to morphological transformation and stress fiber disruption, and is required for migration of Src-transformed cells and for their ability to polarize at the edge of a monolayer. The lambda isoform of aPKC is specifically required for invasion through extracellular matrix in Boyden chamber assays and for degradation of the extracellular matrix in in situ zymography assays. Tyrosine phosphorylation of aPKClambda is required for its ability to promote cell invasion. The defect in invasion upon aPKC inhibition appears to result from a defect in the assembly and/or function of podosomes, invasive adhesions on the ventral surface of the cell that are sites of protease secretion. aPKC was also found to localize to podosomes of v-Src transformed cells, suggesting a direct role for aPKC in podosome assembly and/or function. We conclude that basal or elevated aPKC activity is required for the ability of Src-transformed cells to degrade and invade the extracellular matrix. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19492416      PMCID: PMC2782718          DOI: 10.1002/jcp.21841

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  46 in total

1.  Steroid receptor fusion proteins for conditional activation of Raf-MEK-ERK signaling pathway.

Authors:  M McMahon
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

2.  Phosphorylation of tyrosine 256 facilitates nuclear import of atypical protein kinase C.

Authors:  Wendy O White; M Lamar Seibenhener; Marie W Wooten
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

3.  Activation of protein kinase Czeta is essential for cytokine-induced metalloproteinase-1, -3, and -9 secretion from rabbit smooth muscle cells and inhibits proliferation.

Authors:  Shaista Hussain; Jean W Assender; Mark Bond; Liang-Fong Wong; David Murphy; Andrew C Newby
Journal:  J Biol Chem       Date:  2002-05-08       Impact factor: 5.157

4.  Regulation of cell polarity and protrusion formation by targeting RhoA for degradation.

Authors:  Hong-Rui Wang; Yue Zhang; Barish Ozdamar; Abiodun A Ogunjimi; Evguenia Alexandrova; Gerald H Thomsen; Jeffrey L Wrana
Journal:  Science       Date:  2003-12-05       Impact factor: 47.728

Review 5.  Newest findings on the oldest oncogene; how activated src does it.

Authors:  Margaret C Frame
Journal:  J Cell Sci       Date:  2004-03-01       Impact factor: 5.285

6.  Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway.

Authors:  M W Wooten; M L Vandenplas; M L Seibenhener; T Geetha; M T Diaz-Meco
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

7.  PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells.

Authors:  Antonella Muscella; Simona Greco; Maria Giovanna Elia; Carlo Storelli; Santo Marsigliante
Journal:  J Cell Physiol       Date:  2003-10       Impact factor: 6.384

8.  Molecular mechanisms regulating protein kinase Czeta turnover and cellular transformation.

Authors:  J Ann Le Good; David N Brindley
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

9.  Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function.

Authors:  Rebecca L Berdeaux; Begoña Díaz; Lomi Kim; G Steven Martin
Journal:  J Cell Biol       Date:  2004-08-02       Impact factor: 10.539

10.  Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo.

Authors:  Nicole R Murray; Lee Jamieson; Wangsheng Yu; Jie Zhang; Yesim Gökmen-Polar; Deborah Sier; Panos Anastasiadis; Zoran Gatalica; E Aubrey Thompson; Alan P Fields
Journal:  J Cell Biol       Date:  2004-03-15       Impact factor: 10.539

View more
  13 in total

1.  Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12.

Authors:  Shin Akakura; Peter Nochajski; Lingqiu Gao; Paula Sotomayor; Sei-ichi Matsui; Irwin H Gelman
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

Review 2.  GluA2-dependent AMPA receptor endocytosis and the decay of early and late long-term potentiation: possible mechanisms for forgetting of short- and long-term memories.

Authors:  Oliver Hardt; Karim Nader; Yu-Tian Wang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-02       Impact factor: 6.237

Review 3.  Atypical protein kinase Cι as a human oncogene and therapeutic target.

Authors:  Peter J Parker; Verline Justilien; Philippe Riou; Mark Linch; Alan P Fields
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

Review 4.  ROS-activated calcium signaling mechanisms regulating endothelial barrier function.

Authors:  Anke Di; Dolly Mehta; Asrar B Malik
Journal:  Cell Calcium       Date:  2016-02-17       Impact factor: 6.817

5.  Control of MT1-MMP transport by atypical PKC during breast-cancer progression.

Authors:  Carine Rossé; Catalina Lodillinsky; Laetitia Fuhrmann; Maya Nourieh; Pedro Monteiro; Marie Irondelle; Emilie Lagoutte; Sophie Vacher; François Waharte; Perrine Paul-Gilloteaux; Maryse Romao; Lucie Sengmanivong; Mark Linch; Johan van Lint; Graça Raposo; Anne Vincent-Salomon; Ivan Bièche; Peter J Parker; Philippe Chavrier
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

6.  Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastoma.

Authors:  Yael Kusne; Eugenio A Carrera-Silva; Anthony S Perry; Elisabeth J Rushing; Edward K Mandell; Justin D Dietrich; Andrea E Errasti; Daniel Gibbs; Michael E Berens; Joseph C Loftus; Christopher Hulme; Weiwei Yang; Zhimin Lu; Kenneth Aldape; Nader Sanai; Carla V Rothlin; Sourav Ghosh
Journal:  Sci Signal       Date:  2014-08-12       Impact factor: 8.192

Review 7.  The interplay between the proteolytic, invasive, and adhesive domains of invadopodia and their roles in cancer invasion.

Authors:  Or-Yam Revach; Benjamin Geiger
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

8.  The protein kinase C cascade regulates recruitment of matrix metalloprotease 9 to podosomes and its release and activation.

Authors:  Helan Xiao; Xiao-Hui Bai; Andras Kapus; Wei-Yang Lu; Alan S Mak; Mingyao Liu
Journal:  Mol Cell Biol       Date:  2010-10-11       Impact factor: 4.272

9.  PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention.

Authors:  Sheng Yao; Alix Bee; Daniel Brewer; Andrew Dodson; Carol Beesley; Youqiang Ke; Laurence Ambroisine; Gabrielle Fisher; Heinrich Møller; Tim Dickinson; Patricia Gerard; Lu-Yu Lian; Janet Risk; Brian Lane; Paul Smith; Victor Reuter; Daniel Berney; Christine Gosden; Peter Scardino; Jack Cuzick; Mustafa B A Djamgoz; Colin Cooper; Christopher S Foster
Journal:  Genes Cancer       Date:  2010-05

Review 10.  Atypical protein kinase C in cell motility.

Authors:  Helan Xiao; Mingyao Liu
Journal:  Cell Mol Life Sci       Date:  2012-10-25       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.